IDO inhibitors:  from Bench to Bedside
Professor George C. Prendergast, PhD, President/CEO
Lankenau Institute for Medical Research





                        分页:
                                                                                                            [ 1 ]  
                                                                                                                                                                                            [ 2 ]
                                                                     
                                                                        
                                    